Volume 123, Issue 1 , Pages 35-40, January 2009
Advances in adult asthma diagnosis and treatment and health outcomes, education, delivery, and quality in 2008
In 2008 the Journal reported new findings in management of asthma. Dosing schedules of inhaled steroids have been modified and individualized. New, more costly propellants are replacing ozone-depleting chlorofluorocarbons. An association of asthma with pneumococcal disease has been observed. Smoking bans in public places are eliminating second-hand smoke and reducing asthma-related emergency department visits among adults. In contrast with these advances, however, disparity in asthma morbidity persists: black persons compared with white persons have a 4-fold greater risk of an asthma-related emergency department visit.
Key words: Asthma, adults, genetics, inhaled corticosteroids, exhaled breath condensate, nitric oxide, chlorofluorocarbon, short-acting β-agonists, health literacy
Abbreviations used: AERD, Aspirin-exacerbated respiratory disease, EBC, Exhaled breath condensate, ED, Emergency department, EPR, National Asthma Education and Prevention Program Expert Panel Report, FeNO, Fraction of exhaled nitric oxide, ICS, Inhaled corticosteroid, IVR, Interactive voice-response, SABA, Short-acting β2-agonist
Supported by the National Heart, Lung, and Blood Institute (HL073932, HL088469).
Disclosure of potential conflict of interest: A. Apter has received grant support from the National Heart, Lung, and Blood Institute.
PII: S0091-6749(08)02209-4
doi:10.1016/j.jaci.2008.11.017
© 2009 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Volume 123, Issue 1 , Pages 35-40, January 2009

